{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T19:02:01Z","timestamp":1795201321932,"version":"4.10.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T00:00:00Z","timestamp":1663632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000304","name":"Parkinson&apos;s UK","doi-asserted-by":"publisher","award":["G-1901"],"award-info":[{"award-number":["G-1901"]}],"id":[{"id":"10.13039\/501100000304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000288","name":"Royal Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000288","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Soluble \u03b1-synuclein aggregates varying in size, structure, and morphology have been closely linked to neuronal death in Parkinson\u2019s disease. However, the heterogeneity of different co-existing aggregate species makes it hard to isolate and study their individual toxic properties. Here, we show a reliable non-perturbative method to separate a heterogeneous mixture of protein aggregates by size. We find that aggregates of wild-type \u03b1-synuclein smaller than 200\u2009nm in length, formed during an in vitro aggregation reaction, cause inflammation and permeabilization of single-liposome membranes and that larger aggregates are less toxic. Studying soluble aggregates extracted from post-mortem human brains also reveals that these aggregates are similar in size and structure to the smaller aggregates formed in aggregation reactions in the test tube. Furthermore, we find that the soluble aggregates present in Parkinson\u2019s disease brains are smaller, largely less than 100\u2009nm, and more inflammatory compared to the larger aggregates present in control brains. This study suggests that the small non-fibrillar \u03b1-synuclein aggregates are the critical species driving neuroinflammation and disease progression.<\/jats:p>","DOI":"10.1038\/s41467-022-33252-6","type":"journal-article","created":{"date-parts":[[2022,9,20]],"date-time":"2022-09-20T08:06:57Z","timestamp":1663661217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":233,"title":["Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson\u2019s disease"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3853-664X","authenticated-orcid":false,"given":"Derya","family":"Emin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu P.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeniia","family":"Lobanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9662-8454","authenticated-orcid":false,"given":"Xuecong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5977-9691","authenticated-orcid":false,"given":"Zengjie","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0571-5892","authenticated-orcid":false,"given":"Helen","family":"Dakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios I.","family":"Sideris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7408-2342","authenticated-orcid":false,"given":"Jeff Y. L.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan T.","family":"Ranasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonina","family":"Kouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1675-0773","authenticated-orcid":false,"given":"Suman","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7879-0140","authenticated-orcid":false,"given":"Tuomas P. J.","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3616-1610","authenticated-orcid":false,"given":"Michele","family":"Vendruscolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1232-1907","authenticated-orcid":false,"given":"Francesco S.","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franklin I.","family":"Aigbirhio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2648-9743","authenticated-orcid":false,"given":"Caroline H.","family":"Williams-Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7116-6954","authenticated-orcid":false,"given":"David","family":"Klenerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,20]]},"reference":[{"key":"33252_CR1","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri, S., Mus, L. & Blandini, F. Parkinson\u2019s disease in women and men: what\u2019s the difference? J. Parkinson\u2019s Dis. 9, 501\u2013515 (2019).","journal-title":"J. Parkinson\u2019s Dis."},{"key":"33252_CR2","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.tips.2008.10.005","volume":"30","author":"AHV Schapira","year":"2009","unstructured":"Schapira, A. H. V. Neurobiology and treatment of Parkinson\u2019s disease. Trends Pharmacol. Sci. 30, 41\u201347 (2009).","journal-title":"Trends Pharmacol. Sci."},{"key":"33252_CR3","first-page":"1","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Prim. 3, 1\u201321 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"33252_CR4","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1002\/mds.28216","volume":"35","author":"A Delva","year":"2020","unstructured":"Delva, A., Van Weehaeghe, D., Koole, M., Van Laere, K. & Vandenberghe, W. Loss of presynaptic terminal integrity in the Substantia Nigra in early Parkinson\u2019s disease. Mov. Disord. 35, 1977\u20131986 (2020).","journal-title":"Mov. Disord."},{"key":"33252_CR5","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","volume":"95","author":"MG Spillantini","year":"1998","unstructured":"Spillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M. & Goedert, M. \u03b1-Synuclein in filamentous inclusions of Lewy bodies from Parkinson\u2019s disease and dementia with Lewy bodies. Proc. Natl Acad. Sci. USA 95, 6469\u20136473 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33252_CR6","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","volume":"22","author":"SH Shahmoradian","year":"2019","unstructured":"Shahmoradian, S. H. et al. Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes. Nat. Neurosci. 22, 1099\u20131109 (2019).","journal-title":"Nat. Neurosci."},{"key":"33252_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","volume":"318","author":"H Braak","year":"2004","unstructured":"Braak, H., Ghebremedhin, E., R\u00fcb, U., Bratzke, H. & Del Tredici, K. Stages in the development of Parkinson\u2019s disease-related pathology. Cell Tissue Res. 318, 121\u2013134 (2004).","journal-title":"Cell Tissue Res."},{"key":"33252_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-01083-5","volume":"8","author":"A Kouli","year":"2020","unstructured":"Kouli, A., Camacho, M., Allinson, K. & Williams-Gray, C. H. Neuroinflammation and protein pathology in Parkinson\u2019s disease dementia. Acta Neuropathologica Commun. 8, 1\u201319 (2020).","journal-title":"Acta Neuropathologica Commun."},{"key":"33252_CR9","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/j.cell.2012.03.037","volume":"149","author":"N Cremades","year":"2012","unstructured":"Cremades, N. et al. Direct observation of the interconversion of normal and toxic forms of \u03b1-synuclein. Cell 149, 1048\u20131059 (2012).","journal-title":"Cell"},{"key":"33252_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.bbadis.2011.10.002","volume":"1822","author":"L Breydo","year":"2012","unstructured":"Breydo, L., Wu, J. W. & Uversky, V. N. \u03b1-Synuclein misfolding and Parkinson\u2019s disease. Biochimica et. Biophysica Acta - Mol. Basis Dis. 1822, 261\u2013285 (2012).","journal-title":"Biochimica et. Biophysica Acta - Mol. Basis Dis."},{"key":"33252_CR11","doi-asserted-by":"publisher","first-page":"4194","DOI":"10.1073\/pnas.1100976108","volume":"108","author":"B Winner","year":"2011","unstructured":"Winner, B. et al. In vivo demonstration that \u03b1-synuclein oligomers are toxic. Proc. Natl Acad. Sci. USA 108, 4194\u20134199 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33252_CR12","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.tcb.2014.05.003","volume":"24","author":"MS Hipp","year":"2014","unstructured":"Hipp, M. S., Park, S. H. & Hartl, U. U. Proteostasis impairment in protein-misfolding and -aggregation diseases. Trends Cell Biol. 24, 506\u2013514 (2014).","journal-title":"Trends Cell Biol."},{"key":"33252_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrn3406","volume":"14","author":"HA Lashuel","year":"2013","unstructured":"Lashuel, H. A., Overk, C. R., Oueslati, A. & Masliah, E. The many faces of \u03b1-synuclein: from structure and toxicity to therapeutic target. Nat. Rev. Neurosci. 14, 38\u201348 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"33252_CR14","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","volume":"27","author":"KM Danzer","year":"2007","unstructured":"Danzer, K. M. et al. Different species of \u03b1-synuclein oligomers induce calcium influx and seeding. J. Neurosci. 27, 9220\u20139232 (2007).","journal-title":"J. Neurosci."},{"key":"33252_CR15","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00401-017-1755-1","volume":"134","author":"N Bengoa-Vergniory","year":"2017","unstructured":"Bengoa-Vergniory, N., Roberts, R. F., Wade-Martins, R. & Alegre-Abarrategui, J. Alpha-synuclein oligomers: a new hope. Acta Neuropathologica 134, 819\u2013838 (2017).","journal-title":"Acta Neuropathologica"},{"key":"33252_CR16","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1126\/science.aan6160","volume":"358","author":"G Fusco","year":"2017","unstructured":"Fusco, G. et al. Structural basis of membrane disruption and cellular toxicity by a-synuclein oligomers. Science 358, 1440\u20131443 (2017).","journal-title":"Science"},{"key":"33252_CR17","first-page":"1","volume":"21","author":"XY Du","year":"2020","unstructured":"Du, X. Y., Xie, X. X. & Liu, R. T. The role of \u03b1-synuclein oligomers in parkinson\u2019s disease. Int. J. Mol. Sci. 21, 1\u201317 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"33252_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/annotation\/9282f173-df82-4b70-9120-b4e62b3dacb1","volume":"3","author":"TF Outeiro","year":"2008","unstructured":"Outeiro, T. F. et al. Formation of toxic oligomeric \u03b1-synuclein species in living cells. PLoS ONE 3, 1\u20139 (2008).","journal-title":"PLoS ONE"},{"key":"33252_CR19","doi-asserted-by":"publisher","first-page":"7812","DOI":"10.1021\/bi0102398","volume":"40","author":"MJ Volles","year":"2001","unstructured":"Volles, M. J. et al. Vesicle permeabilization by protofibrillar \u03b1-synuclein: Implications for the pathogenesis and treatment of Parkinson\u2019s disease. Biochemistry 40, 7812\u20137819 (2001).","journal-title":"Biochemistry"},{"key":"33252_CR20","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1073\/pnas.1218424110","volume":"110","author":"BK Choi","year":"2013","unstructured":"Choi, B. K. et al. Large \u03b1-synuclein oligomers inhibit neuronal SNARE-mediated vesicle docking. Proc. Natl Acad. Sci. USA 110, 4087\u20134092 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33252_CR21","doi-asserted-by":"publisher","first-page":"11750","DOI":"10.1523\/JNEUROSCI.0234-12.2012","volume":"32","author":"MJ Di\u00f3genes","year":"2012","unstructured":"Di\u00f3genes, M. J. et al. Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation. J. Neurosci. 32, 11750\u201311762 (2012).","journal-title":"J. Neurosci."},{"key":"33252_CR22","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ana.25557","volume":"86","author":"V Grozdanov","year":"2019","unstructured":"Grozdanov, V. et al. Increased immune activation by pathologic \u03b1-synuclein in Parkinson\u2019s disease. Ann. Neurol. 86, 593\u2013606 (2019).","journal-title":"Ann. Neurol."},{"key":"33252_CR23","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1113\/JP271968","volume":"594","author":"TJ Kaufmann","year":"2016","unstructured":"Kaufmann, T. J., Harrison, P. M., Richardson, M. J. E., Pinheiro, T. J. T. & Wall, M. J. Intracellular soluble \u03b1-synuclein oligomers reduce pyramidal cell excitability. J. Physiol. 594, 2751\u20132772 (2016).","journal-title":"J. Physiol."},{"key":"33252_CR24","doi-asserted-by":"publisher","first-page":"3301","DOI":"10.1523\/JNEUROSCI.5368-11.2012","volume":"32","author":"E Colla","year":"2012","unstructured":"Colla, E. et al. Accumulation of toxic \u03b1-synuclein oligomer within endoplasmic reticulum occurs in \u03b1-synucleinopathy in vivo. J. Neurosci. 32, 3301\u20133305 (2012).","journal-title":"J. Neurosci."},{"key":"33252_CR25","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1016\/j.biocel.2009.05.008","volume":"41","author":"MS Parihar","year":"2009","unstructured":"Parihar, M. S., Parihar, A., Fujita, M., Hashimoto, M. & Ghafourifar, P. Alpha-synuclein overexpression and aggregation exacerbates impairment of mitochondrial functions by augmenting oxidative stress in human neuroblastoma cells. Int. J. Biochem. Cell Biol. 41, 2015\u20132024 (2009).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"33252_CR26","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1093\/brain\/awv376","volume":"139","author":"M Helwig","year":"2016","unstructured":"Helwig, M. et al. Brain propagation of transduced \u03b1-synuclein involves non-fibrillar protein species and is enhanced in \u03b1-synuclein null mice. Brain 139, 856\u2013870 (2016).","journal-title":"Brain"},{"key":"33252_CR27","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice. J. Exp. Med. 209, 975\u2013988 (2012).","journal-title":"J. Exp. Med."},{"key":"33252_CR28","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1093\/brain\/awt037","volume":"136","author":"M Masuda-Suzukake","year":"2013","unstructured":"Masuda-Suzukake, M. et al. Prion-like spreading of pathological \u03b1-synuclein in brain. Brain 136, 1128\u20131138 (2013).","journal-title":"Brain"},{"key":"33252_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00401-018-1907-y","volume":"137","author":"CD Hughes","year":"2019","unstructured":"Hughes, C. D. et al. Picomolar concentrations of oligomeric alpha-synuclein sensitizes TLR4 to play an initiating role in Parkinson\u2019s disease pathogenesis. Acta Neuropathologica 137, 103\u2013120 (2019).","journal-title":"Acta Neuropathologica"},{"key":"33252_CR30","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1016\/j.bbrc.2016.09.109","volume":"479","author":"A Hoffmann","year":"2016","unstructured":"Hoffmann, A. et al. Alpha-synuclein activates BV2 microglia dependent on its aggregation state. Biochem. Biophys. Res. Commun. 479, 881\u2013886 (2016).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"33252_CR31","doi-asserted-by":"crossref","unstructured":"Kim, C. et al. Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat. Commun. 4, 1562 (2013).","DOI":"10.1038\/ncomms2534"},{"key":"33252_CR32","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00401-011-0926-8","volume":"123","author":"G Taschenberger","year":"2012","unstructured":"Taschenberger, G. et al. Aggregation of \u03b1synuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons. Acta Neuropathologica 123, 671\u2013683 (2012).","journal-title":"Acta Neuropathologica"},{"key":"33252_CR33","doi-asserted-by":"publisher","first-page":"10392","DOI":"10.1074\/jbc.RA119.007743","volume":"294","author":"JM Froula","year":"2019","unstructured":"Froula, J. M. et al. Defining \u03b1-synuclein species responsible for Parkinson\u2019s disease phenotypes in mice. J. Biol. Chem. 294, 10392\u201310406 (2019).","journal-title":"J. Biol. Chem."},{"key":"33252_CR34","first-page":"E1994","volume":"112","author":"SW Chen","year":"2015","unstructured":"Chen, S. W. et al. Structural characterization of toxic oligomers that are kinetically trapped during \u03b1-synuclein fibril formation. Proc. Natl Acad. Sci. USA 112, E1994\u2013E2003 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33252_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-21937-3","volume":"12","author":"R Cascella","year":"2021","unstructured":"Cascella, R. et al. The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells. Nat. Commun. 12, 1\u201316 (2021).","journal-title":"Nat. Commun."},{"key":"33252_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0213663","volume":"14","author":"F van Diggelen","year":"2019","unstructured":"van Diggelen, F. et al. Two conformationally distinct \u03b1-synuclein oligomers share common epitopes and the ability to impair long-term potentiation. PLoS ONE 14, 1\u201322 (2019).","journal-title":"PLoS ONE"},{"key":"33252_CR37","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1038\/nn.4641","volume":"20","author":"DE Mor","year":"2017","unstructured":"Mor, D. E. et al. Dopamine induces soluble \u03b1-synuclein oligomers and nigrostriatal degeneration. Nat. Neurosci. 20, 1560\u20131568 (2017).","journal-title":"Nat. Neurosci."},{"key":"33252_CR38","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.bbrc.2018.09.111","volume":"505","author":"P Carmo-Gon\u00e7alves","year":"2018","unstructured":"Carmo-Gon\u00e7alves, P. et al. Exploring the role of methionine residues on the oligomerization and neurotoxic properties of DOPAL-modified \u03b1-synuclein. Biochem. Biophys. Res. Commun. 505, 295\u2013301 (2018).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"33252_CR39","first-page":"1","volume":"8","author":"C Dong","year":"2018","unstructured":"Dong, C. et al. Structural characteristics and membrane interactions of tandem \u03b1-synuclein oligomers. Sci. Rep. 8, 1\u201311 (2018).","journal-title":"Sci. Rep."},{"key":"33252_CR40","doi-asserted-by":"crossref","unstructured":"De, S. et al. Different soluble aggregates of A\u03b242 can give rise to cellular toxicity through different mechanisms. Nat. Commun. 10, 1541 (2019).","DOI":"10.1038\/s41467-019-09477-3"},{"key":"33252_CR41","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1021\/bi061359o","volume":"46","author":"S Maeda","year":"2007","unstructured":"Maeda, S. et al. Granular tau oligomers as intermediates of tau filaments. Biochemistry 46, 3856\u20133861 (2007).","journal-title":"Biochemistry"},{"key":"33252_CR42","doi-asserted-by":"publisher","first-page":"13044","DOI":"10.1021\/acs.analchem.7b04335","volume":"89","author":"G Je","year":"2017","unstructured":"Je, G. et al. Endogenous alpha-synuclein protein analysis from human brain tissues using single-molecule pull-down assay. Anal. Chem. 89, 13044\u201313048 (2017).","journal-title":"Anal. Chem."},{"key":"33252_CR43","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1002\/cbic.201800352","volume":"19","author":"K Spehar","year":"2018","unstructured":"Spehar, K. et al. Super-resolution imaging of amyloid structures over extended times by using transient binding of single thioflavin T molecules. ChemBioChem 19, 1944\u20131948 (2018).","journal-title":"ChemBioChem"},{"key":"33252_CR44","doi-asserted-by":"crossref","unstructured":"Needham, L.-M. et al. ThX \u2013 a next-generation probe for the early detection of amyloid aggregates. Chem. Sci. 11, 4578-4583 (2020).","DOI":"10.1039\/C9SC04730A"},{"key":"33252_CR45","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.abb.2019.02.001","volume":"664","author":"FS Ruggeri","year":"2019","unstructured":"Ruggeri, F. S., \u0160neideris, T., Vendruscolo, M. & Knowles, T. P. J. Atomic force microscopy for single molecule characterisation of protein aggregation. Arch. Biochem. Biophys. 664, 134\u2013148 (2019).","journal-title":"Arch. Biochem. Biophys."},{"key":"33252_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep31155","volume":"6","author":"FS Ruggeri","year":"2016","unstructured":"Ruggeri, F. S. et al. Nanoscale studies link amyloid maturity with polyglutamine diseases onset. Sci. Rep. 6, 1\u201311 (2016).","journal-title":"Sci. Rep."},{"key":"33252_CR47","doi-asserted-by":"publisher","first-page":"7230","DOI":"10.1073\/pnas.1721220115","volume":"115","author":"FS Ruggeri","year":"2018","unstructured":"Ruggeri, F. S. et al. Identification and nanomechanical characterization of the fundamental single-strand protofilaments of amyloid \u03b1-synuclein fibrils. Proc. Natl Acad. Sci. USA 115, 7230\u20137235 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33252_CR48","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1021\/acsnano.9b09676","volume":"14","author":"FS Ruggeri","year":"2020","unstructured":"Ruggeri, F. S. et al. The influence of pathogenic mutations in \u03b1-synuclein on biophysical and structural characteristics of amyloid fibrils. ACS Nano 14, 5213\u20135222 (2020).","journal-title":"ACS Nano"},{"key":"33252_CR49","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1002\/anie.201409050","volume":"54","author":"FS Ruggeri","year":"2015","unstructured":"Ruggeri, F. S. et al. Influence of the \u03b2-sheet content on the mechanical properties of aggregates during amyloid fibrillization. Angew. Chem. - Int. Ed. 54, 2462\u20132466 (2015).","journal-title":"Angew. Chem. - Int. Ed."},{"key":"33252_CR50","doi-asserted-by":"publisher","first-page":"7873","DOI":"10.1021\/ja075356q","volume":"130","author":"J Madine","year":"2008","unstructured":"Madine, J., Doig, A. J. & Middleton, D. A. Design of an N-methylated peptide inhibitor of \u03b1-synuclein aggregation guided by solid-state NMR. J. Am. Chem. Soc. 130, 7873\u20137881 (2008).","journal-title":"J. Am. Chem. Soc."},{"key":"33252_CR51","doi-asserted-by":"publisher","first-page":"6252","DOI":"10.1021\/bi5007833","volume":"53","author":"W Paslawski","year":"2014","unstructured":"Paslawski, W. et al. High stability and cooperative unfolding of \u03b1-Synuclein Oligomers. Biochemistry 53, 6252\u20136263 (2014).","journal-title":"Biochemistry"},{"key":"33252_CR52","doi-asserted-by":"publisher","first-page":"9365","DOI":"10.1523\/JNEUROSCI.1504-06.2006","volume":"26","author":"MK McCoy","year":"2006","unstructured":"McCoy, M. K. et al. Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson\u2019s disease. J. Neurosci. 26, 9365\u20139375 (2006).","journal-title":"J. Neurosci."},{"key":"33252_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00401-018-1846-7","volume":"136","author":"W Hong","year":"2018","unstructured":"Hong, W. et al. Diffusible, highly bioactive oligomers represent a critical minority of soluble A\u03b2 in Alzheimer\u2019s disease brain. Acta Neuropathologica 136, 19\u201340 (2018).","journal-title":"Acta Neuropathologica"},{"key":"33252_CR54","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.1002\/cbic.201800209","volume":"19","author":"DR Whiten","year":"2018","unstructured":"Whiten, D. R. et al. Nanoscopic characterisation of individual endogenous protein aggregates in human neuronal cells. ChemBioChem 19, 2033\u20132038 (2018).","journal-title":"ChemBioChem"},{"key":"33252_CR55","doi-asserted-by":"crossref","unstructured":"Bousset, L. et al. Structural and functional characterization of two alpha-synuclein strains. Nat. Commun. 4, 2575 (2013).","DOI":"10.1038\/ncomms3575"},{"key":"33252_CR56","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature14547","volume":"522","author":"W Peelaerts","year":"2015","unstructured":"Peelaerts, W. et al. \u03b1-Synuclein strains cause distinct synucleinopathies after local and systemic administration. Nature 522, 340\u2013344 (2015).","journal-title":"Nature"},{"key":"33252_CR57","doi-asserted-by":"crossref","unstructured":"Sehlin, D. et al. Large aggregates are the major soluble A\u03b2 species in AD brain fractionated with density gradient ultracentrifugation. PLoS ONE 7, e32014 (2012).","DOI":"10.1371\/journal.pone.0032014"},{"key":"33252_CR58","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"33252_CR59","doi-asserted-by":"crossref","unstructured":"Sideris, D. I. et al. Soluble amyloid beta-containing aggregates are present throughout the brain at early stages of Alzheimer\u2019 s disease. Brain Commun. 3, fcab147 (2021).","DOI":"10.1093\/braincomms\/fcab147"},{"key":"33252_CR60","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/S0022-2836(02)00775-1","volume":"322","author":"W Hoyer","year":"2002","unstructured":"Hoyer, W. et al. Dependence of \u03b1-synuclein aggregate morphology on solution conditions. J. Mol. Biol. 322, 383\u2013393 (2002).","journal-title":"J. Mol. Biol."},{"key":"33252_CR61","doi-asserted-by":"publisher","first-page":"7750","DOI":"10.1002\/anie.201700966","volume":"56","author":"P Flagmeier","year":"2017","unstructured":"Flagmeier, P. et al. Ultrasensitive measurement of Ca2+ influx into lipid vesicles induced by protein aggregates. Angew. Chem. - Int. Ed. 56, 7750\u20137754 (2017).","journal-title":"Angew. Chem. - Int. Ed."},{"key":"33252_CR62","doi-asserted-by":"publisher","unstructured":"Chandradoss, S. D. et al. Surface passivation for single-molecule protein studies. J. Vis. Exp. 1\u20138 https:\/\/doi.org\/10.3791\/50549 (2014).","DOI":"10.3791\/50549"},{"key":"33252_CR63","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/s41557-020-0506-4","volume":"12","author":"M Di Antonio","year":"2020","unstructured":"Di Antonio, M. et al. Single-molecule visualization of DNA G-quadruplex formation in live cells. Nat. Chem. 12, 832\u2013837 (2020).","journal-title":"Nat. Chem."},{"key":"33252_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-75785-0","volume":"10","author":"F Marques-Moros","year":"2020","unstructured":"Marques-Moros, F., Forment-Aliaga, A., Pinilla-Cienfuegos, E. & Canet-Ferrer, J. Mirror effect in atomic force microscopy profiles enables tip reconstruction. Sci. Rep. 10, 1\u20138 (2020).","journal-title":"Sci. Rep."},{"key":"33252_CR65","doi-asserted-by":"crossref","unstructured":"Laine, R. F. et al. NanoJ: a high-performance open-source super-resolution microscopy toolbox. J. Phys. D: Appl. Phys. 52, 163001 (2019).","DOI":"10.1088\/1361-6463\/ab0261"},{"key":"33252_CR66","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1093\/bioinformatics\/btu202","volume":"30","author":"M Ovesn\u00fd","year":"2014","unstructured":"Ovesn\u00fd, M., K\u0159\u00ed\u017eek, P., Borkovec, J., \u0160vindrych, Z. & Hagen, G. M. ThunderSTORM: a comprehensive ImageJ plug-in for PALM and STORM data analysis and super-resolution imaging. Bioinformatics 30, 2389\u20132390 (2014).","journal-title":"Bioinformatics"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33252-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33252-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33252-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T09:44:12Z","timestamp":1664963052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33252-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,20]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["33252"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-33252-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,20]]},"assertion":[{"value":"3 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5512"}}